Cervical Cancer Diagnostic Market Size, Share Report, Analysis, Trends, Growth 2032

Cervical Cancer Diagnostics Market: Industry Prospective

The global Cervical Cancer Diagnostics market size accrued earnings worth approximately USD 4.78 Billion in 2023 and is predicted to gain revenue of about USD 7.80 Billion by 2032, is set to record a CAGR of nearly 5.72% over the period from 2024 to 2032.

Request Free Sample

Cervical Cancer Diagnostics Market Overview

Cancer is a group of diseases involving abnormal growth of cells with the potential to spread to other parts of the body. There are various types of cancers affecting different parts of body. Cancer which develops in cervix is called cervical cancer. Two major types of cervical cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early detection and vaccination.

Request Free Sample

Cervical Cancer Diagnostics Market Growth Dynamics

Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV infected people across globe. HPV is an extremely common virus. According to the Centers for Disease Control and Prevention (CDC), six million people in the United States acquire HPV each year.  At least 20 million already have it, and more than half of all sexually-active adults are expected to be infected during their lifetime. Furthermore, rising awareness, literacy rate, government initiatives, government funding and various screening methods are expected to increase the growth of the market over the years. Moreover, many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV positive patients, are estimated to drive the cervical diagnostics market in the near future. However prevention of HPV by vaccination is major restraining factor in the growth of cervical cancer diagnostics market. In addition to this, the uncertain returning policy serves to be a major challenge impacting the growth of cervical cancer diagnostics market.

Cervical Cancer Diagnostics Market: Report Scope

The report covers forecast and analysis of the cervical cancer diagnostics market on a global and regional level. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the cervical cancer diagnostics market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

Cervical Cancer Diagnostics Market: Segmentation Analysis

The report provides detailed segmentation of the cervical cancer diagnostics market based on Product Type, Stages, Age Group, Distribution Channel, and Region. The regional market segment held the largest market share in 2023.

The cervical cancer diagnostic market is divided into different categories, including product type, age range, stages, end users, and distribution channel on a global scale. Examining the growth within these specific sectors will assist in analyzing areas of little growth within the industries. This analysis will offer users a valuable industry overview and insights, enabling them to make strategic decisions and find key market opportunities.

Different product types, such as imaging tests, screening tests, visual examinations, cervical biopsies, and other treatments, divide the global cervical cancer diagnostic market into distinct segments.

Age groups below 21, 21–29, 30-65, and 65 and above make up the global cervical cancer diagnostic market.

Based on the stage of the disease, we categorize the global cervical cancer diagnostic market into stages I, II, III, and IV.

Based on end users, we categorize the global cervical cancer diagnostic market into hospitals, diagnostic laboratories, specialty clinics, community health centers, cancer research organizations, and cancer and radiation therapy centers.

The distribution channel divides the global cervical cancer diagnostic market into direct tender, retail sales, and online sales.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cervical cancer diagnostic market in 2023 on account of the rising incidence of HPV infection, rising number of women smokers, and growing aged population. North America was followed by Europe in 2015. The market is expected to witness the growth in the Asia-Pacific region in the coming years due to the rising HPV infection in population, government initiative and availability of advance health care infrastructure.

Some of the key players contributing to the cervical cancer diagnostics market are

• Abbott
• Hologic, Inc.
• Quest Diagnostics Incorporated
• Bio-Rad Laboratories, Inc.
• Siemens Healthcare GmbH
• BD
• F. Hoffmann-La Roche Ltd
• QIAGEN
• The Cooper Companies Inc.
• Seegene Inc.
• Sysmex Corporation
• MobileODT
• Zilico
• Jiangsu Mole Bioscience Co. Ltd.
• Guided Therapeutics, Inc.
• GenomeMe Lab Inc.
• Arbor Vita Corporation
• and LCM GENECT Srl among others.

This report segments the cervical cancer diagnostics market are follows:-

By Product Type

• Cervical Biopsies
• Imaging Test
• Screening Test
• Visual Examination
• and Other Procedures

By Age Group

• Below 21
• 21-29
• 30-65
• 65 and Above

By Stages

• Stage I
• Stage II
• Stage III
• Stage IV

By End Users

• Hospitals
• Diagnostic Laboratories
• Specialty Clinics
• Community Health Centers
• Cancer Research Organization
• Cancer and Radiation Therapy Centers

By Distribution Channel

• Direct Tender
• Retail Sales
• Online Sales

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa